The lifetime risk of developing bipolar II disorder is 5-7%, yet the condition is often poorly detected. Mood elevation states are less extreme than in bipolar I disorder although the depressive episodes are usually severe. When correctly treated, the outcome is positive, but bipolar II is often poorly managed, resulting in a high suicide rate. This is the only academic and clinical management review focusing entirely on bipolar II, scrutinizing history, epidemiology, burden and neurobiology and including an extensive clinical debate by international experts about effective management strategies. New chapters cover comorbidity, over-represented personality styles, illness 'trajectories' and distinguishing bipolar II from personality-based emotional dysregulation states. Evidence for different clinical management options is reviewed in detail, two clinical management models are presented and then debated. This book is essential reading for all health professionals managing mood disorders and informative to patients seeking information about their condition and treatment options. Contents: Introduction to the second edition
1. Bipolar disorder in historical perspective Edward Shorter
2. The bipolar spectrum James Phelps
3. Defining and measuring bipolar II disorder Gordon Parker
4. Bipolar II disorder in context: a review of epidemiology, disability and economic burden George Hadjipavlou, David J. Bond and Lakshmi N. Yatham
5. Comorbid conditions associated with bipolar II disorder Gordon Parker
6. Is bipolar II disorder increasing in prevalence? Gordon Parker
7. Personality styles associated with bipolar II disorder Kathryn Fletcher
8. Distinguishing bipolar II disorder from personality-based states of emotional dysregulation Joel Paris
9. The neurobiology of bipolar II disorder Emre Bora and Christos Pantellis
10. The role of antidepressants in managing bipolar II disorder Joseph Goldberg
11. Current status of mood stabilisers in the management of bipolar II disorder George Hadjipavlou, David J. Bond and Lakshmi Yatham
12. The use of atypical antipsychotic drugs in bipolar II disorder Eduard Vieta and Nuria Cruz
13. The role of fish oil in managing bipolar II disorder Anne-Marie Rees
14. Psychological interventions for bipolar II disorder Vijaya Manicavasagar and David Gilfillin
15. The role of wellbeing plans in managing bipolar II disorder Margo Orum
16. The trajectory of illness experienced by those with bipolar II disorder Tessa Cleradin
17. Clinical models for managing bipolar II disorder: model one Gordon Parker
18. Clinical models for managing bipolar II disorder: model two Terence Ketter and Po Wang
19. Management commentary 1 Darryl Bassett
20. Management commentary 2 Michael Berk
21. Management commentary 3 Sophia Frangou
22. Management commentary 4 Mark Frye
23. Management commentary 5 S. Nassir Ghaemi
24. Management commentary 6 Michael Gitlin and David Miklowitz
25. Management commentary 7 Joseph Goldberg
26. Management commentary 8 Guy Goodwin
27. Management commentary 9 Andrew Nierenberg
28. Management commentary 10 Robert Post
29. Management commentary 11 Michael Thase
30. Management commentary 12 Eduard Vieta
31. Management commentary 13 Allan Young
32. Rounding up and tying down Gordon Parker
Index. About the Editor: Gordon Parker is Scientia Professor at the School of Psychiatry, Faculty of Medicine, University of New South Wales, Sydney, Australia and based at the Black Dog Institute.
|
